UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The epigenetic regulator PLZF represses L1 retrotransposition in germ and progenitor cells

The EMBO journal, 2013-07, Vol.32 (13), p.1941-1952

2013

Volltextzugriff (PDF)

High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia

Blood cancer journal (New York), 2018-07, Vol.8 (8), p.68-12, Article 68

2018

Volltextzugriff (PDF)

Normal Hematopoietic Progenitor Subsets Have Distinct Reactive Oxygen Species, BCL2 and Cell-Cycle Profiles That Are Decoupled from Maturation in Acute Myeloid Leukemia

PloS one, 2016-09, Vol.11 (9), p.e0163291-e0163291

2016

Volltextzugriff (PDF)

RARα-PLZF overcomes PLZF-mediated repression of CRABPI, contributing to retinoid resistance in t(11;17) acute promyelocytic leukemia

Proceedings of the National Academy of Sciences - PNAS, 2007-11, Vol.104 (47), p.18694-18699

2007

Volltextzugriff (PDF)

Development of real-time quantitative polymerase chain reaction assays to track treatment response in retinoid resistant acute promyelocytic leukemia

Frontiers in oncology, 2011, Vol.1, p.35-35

2011

Volltextzugriff (PDF)

Clinical impact of BAALC expression in high-risk acute promyelocytic leukemia

Blood advances, 2017-09, Vol.1 (21), p.1807-1814

2017

Volltextzugriff (PDF)

Molecular pathogenesis of secondary acute promyelocytic leukemia

Mediterranean journal of hematology and infectious diseases, 2011, Vol.3 (1), p.e2011045-e2011045

2011

Volltextzugriff (PDF)

Defining minimal residual disease in acute myeloid leukemia: which platforms are ready for “prime time”?

Hematology, 2014-12, Vol.2014 (1), p.222-233

2014

Volltextzugriff (PDF)

NPM1 mutation in AML: WHO and why?

Blood, 2006-12, Vol.108 (13), p.3965-3965

Grimwade, David

2006

Volltextzugriff (PDF)

Molecular markers in acute myeloid leukaemia : PIH: How to improve the outcome of adult acute myeloid leukemia?

International journal of hematology, 2012, Vol.96 (2), p.153-163

2012

Volltextzugriff (PDF)

Diagnostic and Prognostic Value of Cytogenetics in Acute Myeloid Leukemia: Acute Leukemia

Hematology/oncology clinics of North America, 2011, Vol.25 (6)

2011

Volltextzugriff (PDF)

The importance of diagnostic cytogenetics on outcome in AML : Analysis of 1,612 patients entered into the MRC AML 10 trial

Blood, 1998-10, Vol.92 (7), p.2322-2333

1998

Volltextzugriff (PDF)

Long Term Follow up from the NCRI AML17 Trial of Attenuated Arsenic Trioxide and ATRA Therapy for Newly Diagnosed and Relapsed Acute Promyelocytic Leukaemia

Blood, 2016-12, Vol.128 (22), p.897-897

2016

Volltextzugriff (PDF)

Therapy-Related Myeloid Neoplasms with Balanced Chromosome Rearrangements Frequently Arise from Pre-Existing Clonal Haematopoiesis

Blood, 2018-11, Vol.132 (Supplement 1), p.2570-2570

2018

Volltextzugriff (PDF)

Pre-Transplant NPM1 Mutant Transcript Level Is Highly Predictive of Outcome after Allograft and Thresholds Are Dependent on FLT3 ITD Status

Blood, 2018-11, Vol.132 (Supplement 1), p.2739-2739

2018

Volltextzugriff (PDF)

Presenting White Blood Cell Count and Kinetics of Molecular Remission Predict Prognosis in Acute Promyelocytic Leukemia Treated With All-Trans Retinoic Acid: Result of the Randomized MRC Trial

Blood, 1999-06, Vol.93 (12), p.4131-4143

1999

Volltextzugriff (PDF)

Identification of PLZF-Dmrs in Hematopoiesis Highlight a Novel Role of PLZF As a Guardian of Hematopoietic Genome Integrity

Blood, 2014-12, Vol.124 (21), p.2904-2904

2014

Volltextzugriff (PDF)

Prognostic Significance and Risk Stratification in Acute Myeloid Leukaemia Patients in the Absence of Successful Cytogenetic Analysis

Blood, 2015-12, Vol.126 (23), p.1379-1379

2015

Volltextzugriff (PDF)

Pml Nuclear Body Disruption Cooperates in APL Pathogenesis, Impacting DNA Damage Repair Pathways

Blood, 2016-12, Vol.128 (22), p.742-742

2016

Volltextzugriff (PDF)

Lineage Deconvolution Using Chromatin Accessibility and DNA Methylation Shows a Spectrum of Lineage Characteristics and Differentiation States across Acute Leukemias

Blood, 2017-12, Vol.130, p.1208-1208

2017

Volltextzugriff (PDF)

Flow Cytometric Minimal Residual Disease As Risk Stratification Tool in Younger Adults with NPM1 Wild Type Standard Risk Acute Myeloid Leukemia

Blood, 2017-12, Vol.130, p.468-468

2017

Volltextzugriff (PDF)

HMGA2 Gene Expression Profile Improves Risk Stratification in Acute Myeloid Leukemia

Blood, 2017-12, Vol.130, p.1402-1402

2017

Volltextzugriff (PDF)

Comprehensive genomic screens identify a role for PLZF-RARα as a positive regulator of cell proliferation via direct regulation of c-MYC

Blood, 2009-12, Vol.114 (27), p.5499-5511

2009

Volltextzugriff (PDF)

1 – 25 von 115

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(111)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Life Sciences & Biomedicine
(20)
Biological And Medical Sciences
(16)
Hematology
(16)
Medical Sciences
(15)
Hematologic And Hematopoietic Diseases
(13)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(13)
Chemotherapy
(6)
Leukemia
(6)
Acute Myeloid Leukemia
(5)
Cytogenetics
(5)
Infectious Diseases
(5)
Immunology
(4)
Microbiology
(3)
Minimal Residual Disease
(3)
Oncology
(3)
Remission
(3)
Acute Myeloid Leukaemia
(2)
Acute Promyelocytic Leukaemia
(2)
Atra
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The epigenetic regulator PLZF represses L1 retrotransposition in germ and progenitor cells

High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia

Normal Hematopoietic Progenitor Subsets Have Distinct Reactive Oxygen Species, BCL2 and Cell-Cycle Profiles That Are Decoupled from Maturation in Acute Myeloid Leukemia

RARα-PLZF overcomes PLZF-mediated repression of CRABPI, contributing to retinoid resistance in t(11;17) acute promyelocytic leukemia

Development of real-time quantitative polymerase chain reaction assays to track treatment response in retinoid resistant acute promyelocytic leukemia

Clinical impact of BAALC expression in high-risk acute promyelocytic leukemia

Molecular pathogenesis of secondary acute promyelocytic leukemia

Defining minimal residual disease in acute myeloid leukemia: which platforms are ready for “prime time”?

NPM1 mutation in AML: WHO and why?

Molecular markers in acute myeloid leukaemia : PIH: How to improve the outcome of adult acute myeloid leukemia?

Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study

Diagnostic and Prognostic Value of Cytogenetics in Acute Myeloid Leukemia: Acute Leukemia

The importance of diagnostic cytogenetics on outcome in AML : Analysis of 1,612 patients entered into the MRC AML 10 trial

Long Term Follow up from the NCRI AML17 Trial of Attenuated Arsenic Trioxide and ATRA Therapy for Newly Diagnosed and Relapsed Acute Promyelocytic Leukaemia

Therapy-Related Myeloid Neoplasms with Balanced Chromosome Rearrangements Frequently Arise from Pre-Existing Clonal Haematopoiesis

Pre-Transplant NPM1 Mutant Transcript Level Is Highly Predictive of Outcome after Allograft and Thresholds Are Dependent on FLT3 ITD Status

Presenting White Blood Cell Count and Kinetics of Molecular Remission Predict Prognosis in Acute Promyelocytic Leukemia Treated With All-Trans Retinoic Acid: Result of the Randomized MRC Trial

Identification of PLZF-Dmrs in Hematopoiesis Highlight a Novel Role of PLZF As a Guardian of Hematopoietic Genome Integrity

Prognostic Significance and Risk Stratification in Acute Myeloid Leukaemia Patients in the Absence of Successful Cytogenetic Analysis

Pml Nuclear Body Disruption Cooperates in APL Pathogenesis, Impacting DNA Damage Repair Pathways

Lineage Deconvolution Using Chromatin Accessibility and DNA Methylation Shows a Spectrum of Lineage Characteristics and Differentiation States across Acute Leukemias

Flow Cytometric Minimal Residual Disease As Risk Stratification Tool in Younger Adults with NPM1 Wild Type Standard Risk Acute Myeloid Leukemia

HMGA2 Gene Expression Profile Improves Risk Stratification in Acute Myeloid Leukemia

Comprehensive genomic screens identify a role for PLZF-RARα as a positive regulator of cell proliferation via direct regulation of c-MYC

Combining Gene Mutation with Gene Expression Data Improves Outcomes Prediction in Acute Promyelocytic Leukemia

Aktive Filter

Suchergebnisse filtern